3,4-dihydroxyphenylacetic acid has been researched along with Gelineau Syndrome in 9 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Excerpt | Relevance | Reference |
---|---|---|
"The other had the sole symptom of excessive daytime sleepiness, confirmed by sleep latency tests, which was unaccompanied by systemic illness." | 1.27 | Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia. ( Barchas, JD; Berger, PA; Faull, KF; Guilleminault, C, 1983) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (66.67) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Krief, S | 1 |
Berrebi-Bertrand, I | 1 |
Nagmar, I | 1 |
Giret, M | 1 |
Belliard, S | 1 |
Perrin, D | 1 |
Uguen, M | 1 |
Robert, P | 1 |
Lecomte, JM | 1 |
Schwartz, JC | 1 |
Finance, O | 1 |
Ligneau, X | 1 |
Faull, KF | 5 |
Barchas, JD | 4 |
Foutz, AS | 3 |
Dement, WC | 5 |
Holman, RB | 2 |
Mefford, IN | 1 |
Baker, TL | 1 |
Boehme, R | 1 |
Ciaranello, RD | 2 |
Guilleminault, C | 2 |
Berger, PA | 1 |
Nishino, S | 1 |
Fujiki, N | 1 |
Ripley, B | 1 |
Sakurai, E | 1 |
Kato, M | 1 |
Watanabe, T | 1 |
Mignot, E | 1 |
Yanai, K | 1 |
Faull, K | 1 |
Miller, JD | 1 |
Bowersox, SS | 2 |
Thiemann, S | 1 |
King, RJ | 1 |
Kilduff, TS | 1 |
Zeller-DeAmicis, L | 1 |
9 other studies available for 3,4-dihydroxyphenylacetic acid and Gelineau Syndrome
Article | Year |
---|---|
Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Carbamates; Corp | 2021 |
Monoamine metabolite concentrations in the cerebrospinal fluid of normal and narcoleptic dogs.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Dogs; Homovanillic Acid; Humans; Hydroxyin | 1982 |
Narcolepsy: biogenic amine deficits in an animal model.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Disease Models, Animal; Dogs; Dopamine; Ep | 1983 |
Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Amino Acids; Disorders of Excessive Somnolence; Female; | 1983 |
Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Chemistry; Cerebral Cortex; Chromatography, Hi | 2001 |
The concentrations of amine metabolites in cerebrospinal fluid from normal and narcoleptic dogs [proceedings].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dogs; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; | 1979 |
CNS monoamines and their metabolites in canine narcolepsy: a replication study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Disease Models, Animal; Dogs; Dopamine; Hydroxyindol | 1990 |
Monoamine interactions in narcolepsy and hypersomnia: a preliminary report.
Topics: 3,4-Dihydroxyphenylacetic Acid; Biogenic Amines; Brain; Dopamine; Homovanillic Acid; Humans; Hydroxy | 1986 |
Brain dopamine receptor levels elevated in canine narcolepsy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Brain Chemistry; Caudate Nucleus; Dogs; Dopamine; | 1987 |